1. < Breast Cancer
Profile picture for colely

ErSO-TFPy human trials soon?

Posted by colely @colely, Mar 2 8:19am

The Hergenrother Laboratory, run by Paul Hergenrother, PhD, at the University of Illinois Urbana-Champaign, is continuing its work on ErSO-TFPy. In small breast cancer tumors in mice, that were ER positive, a single dose eliminated the tumors entirely with very little side effects. The compound has been registered to Bayer AG for further development towards human clinical trials. They may begin 2026!

Interested in more discussions like this? Go to the Breast Cancer Support Group.

Profile picture for coco46
coco46 | @coco46 | Mar 11 4:00pm

Wow, I had no idea about this even being in the works. If it pans out, it really could be a huge game changer for ER+ breast cancer.

REPLY
Profile picture for prarysky
prarysky | @prarysky | Mar 12 12:05pm

Intriguing research for sure. Here's some additional information if interested. Thanks for posting this colely!
https://www.insideprecisionmedicine.com/topics/oncology/breast-cancer-tumors-in-mice-eliminated-by-single-dose-erso-tfpy/

REPLY
Please sign in or register to post a reply.